Where is the money going, if not for research, development, and distribution of life-saving drugs?
What happens when a large pharmaceutical company isn't spending their government funding the way they're supposed to be spending it?
For FBI Agent Ron Fenner, that question hits close to home. His sister Cheri writes a class research paper highlighting how government funding can be misappropriated. Her ex-husband Roger happens to be responsible for overseeing government funding in the very pharmaceutical company Cheri picks to write about.
But there's more to all this. Where big money is involved, criminal elements quickly insert themselves. Is Cheri's abduction orchestrated by the same shadowy entity that's driving Roger's financial decisions? And is that entity the one Ron has encountered twice before? If so, both Cheri and Roger are in real danger. Will Ron be able to prevent either of them from becoming a loose end that needs elimination?
In this third book in the Unexpected Benefits series, the noose tightens. But does it tighten enough to finally put an end to the organization's misdeeds? They have a lot to answer for. Come along for the ride and find out!